Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Using Tumor-Informed Circulating Tumor DNA (ctDNA)-Based Testing for Patients with Anal Squamous Cell Carcinoma.

The oncologist - 17 Mar 2023

Azzi Georges, Tavallai Mehrad, Aushev Vasily N, Koyen Malashevich Allyson, Botta Gregory P, Tejani Mohamedtaki A, Hanna Diana, Krinshpun Shifra, Malhotra Meenakshi, Jurdi Adham, Aleshin Alexey, Kasi Pashtoon M

Abstract excerpt

BACKGROUND: Anal squamous cell carcinoma (SCCA) is an uncommon malignancy with a rising incidence that has a high cure rate in its early stages. There is an unmet need for a reliable method to monitor response to treatment and assist in surveillance. Circulating tumor DNA (ctDNA) testing has shown great promise in other solid tumors for monitoring disease progression and detecting relapse in real time. This study...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anus Neoplasms
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carcinoma, Squamous Cell

Share to Cell-Free Nucleic Acids

Share to Circulating Tumor DNA

Share to DNA, Neoplasm

Share to Mutation

Share to Neoplasm Recurrence, Local

Source

Open in PubMed Open full text

Identifiers

PMID: 36562592
DOI: 10.1093/oncolo/oyac249
PMCID: PMC10020810

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Using Tumor-Informed Circulating Tumor DNA (ctDNA)-Based Testing for Patients with Anal Squamous Cell Carcinoma.PMID 36562592Read ↗

Mutational Signature Changes in Patients With Metastatic Squamous Cell Carcinoma of the Anal Canal.Semantic proximity Read ↗

Frequent tumor burden monitoring of esophageal squamous cell carcinoma with circulating tumor DNA using individually designed digital PCRSemantic proximity Read ↗

Personalized Cancer Monitoring Assay for the Detection of ctDNA in Patients with Solid Tumors.Semantic proximity Read ↗

ctDNA analysis in the personalized clinical management of gastroesophageal adenocarcinoma: turning hope into reality.Semantic proximity Read ↗

In-depth assessment of BRAF, NRAS, KRAS, EGFR, and PIK3CA mutations on cell-free DNA in the blood of melanoma patients receiving immune checkpoint inhibitionSemantic proximity Read ↗

Transcriptomic Immune-related Signature Predictive of Chemoradiotherapy Response in Anal Squamous Cell CarcinomaSemantic proximity Read ↗

Genomic Evolution after Chemoradiotherapy in Anal Squamous Cell Carcinoma.Semantic proximity Read ↗

Genome-wide and panel-based cell-free DNA characterization of patients with resectable esophageal adenocarcinoma.Semantic proximity Read ↗

Transcriptomic Immune-related Signature Predictive of Chemoradiotherapy Response in Anal Squamous Cell CarcinomaSemantic proximity Read ↗

Comprehensive Genomic Profiling of Metastatic Squamous Cell Carcinoma of the Anal Canal.Semantic proximity Read ↗

Molecular and genomic characterisation of a panel of human anal cancer cell lines.Semantic proximity Read ↗

Comprehensive genomic profiling of anal squamous cell carcinoma reveals distinct genomically defined classes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.